These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27638611)

  • 1. Quantum dots and potential therapy for Krabbe's disease.
    Dawson G
    J Neurosci Res; 2016 Nov; 94(11):1293-303. PubMed ID: 27638611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for Krabbe's disease: Finding the combination.
    Mikulka CR; Sands MS
    J Neurosci Res; 2016 Nov; 94(11):1126-37. PubMed ID: 27638598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chaperones as potential therapeutics for Krabbe disease.
    Graziano AC; Pannuzzo G; Avola R; Cardile V
    J Neurosci Res; 2016 Nov; 94(11):1220-30. PubMed ID: 27638605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Negative Charge in the Delivery of Quantum Dots to Neurons.
    Walters R; Medintz IL; Delehanty JB; Stewart MH; Susumu K; Huston AL; Dawson PE; Dawson G
    ASN Neuro; 2015; 7(4):. PubMed ID: 26243591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological considerations for treating globoid cell leukodystrophy.
    Karumuthil-Melethil S; Gray SJ
    J Neurosci Res; 2016 Nov; 94(11):1349-58. PubMed ID: 27638617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.
    Jang DS; Ye W; Guimei T; Solomon M; Southall N; Hu X; Marugan J; Ferrer M; Maegawa GH
    J Neurosci Res; 2016 Nov; 94(11):1231-45. PubMed ID: 27638606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.
    Won JS; Singh AK; Singh I
    J Neurosci Res; 2016 Nov; 94(11):990-1006. PubMed ID: 27638584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion tensor imaging: A biomarker of outcome in Krabbe's disease.
    Poretti A; Meoded A; Fatemi A
    J Neurosci Res; 2016 Nov; 94(11):1108-15. PubMed ID: 27638596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones.
    Spratley SJ; Deane JE
    J Neurosci Res; 2016 Nov; 94(11):1203-19. PubMed ID: 27638604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospects.
    Hu P; Li Y; Nikolaishvili-Feinberg N; Scesa G; Bi Y; Pan D; Moore D; Bongarzone ER; Sands MS; Miller R; Kafri T
    J Neurosci Res; 2016 Nov; 94(11):1152-68. PubMed ID: 27638600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease.
    Béchet S; O'Sullivan SA; Yssel J; Fagan SG; Dev KK
    J Neurosci; 2020 Apr; 40(15):3104-3118. PubMed ID: 32127495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Krabbe's disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathies.
    Marshall MS; Bongarzone ER
    J Neurosci Res; 2016 Nov; 94(11):1328-32. PubMed ID: 27638614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krabbe disease: New hope for an old disease.
    Bradbury AM; Bongarzone ER; Sands MS
    Neurosci Lett; 2021 May; 752():135841. PubMed ID: 33766733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
    Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
    Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Globoid cell leukodystrophy (Krabbe's disease): update.
    Suzuki K
    J Child Neurol; 2003 Sep; 18(9):595-603. PubMed ID: 14572137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of individual mutations and haplotypes in the galactocerebrosidase gene identified by the newborn screening program in New York State and in confirmed cases of Krabbe's disease.
    Saavedra-Matiz CA; Luzi P; Nichols M; Orsini JJ; Caggana M; Wenger DA
    J Neurosci Res; 2016 Nov; 94(11):1076-83. PubMed ID: 27638593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease).
    Suzuki K
    Neuropediatrics; 1984 Sep; 15 Suppl():32-6. PubMed ID: 6152811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for Krabbe's disease.
    Orsini JJ; Saavedra-Matiz CA; Gelb MH; Caggana M
    J Neurosci Res; 2016 Nov; 94(11):1063-75. PubMed ID: 27638592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspective on innovative therapies for globoid cell leukodystrophy.
    Ricca A; Gritti A
    J Neurosci Res; 2016 Nov; 94(11):1304-17. PubMed ID: 27638612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate reduction therapy for Krabbe's disease.
    Sands SA; LeVine SM
    J Neurosci Res; 2016 Nov; 94(11):1261-72. PubMed ID: 27638608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.